Impaired gamma interferon response to Mycobacterium vaccae antigens in patients with cavitary pulmonary tuberculosis

Clinical and Vaccine Immunology

Volumn 15, Issue 9, 2008, Pages 1485-1488

  Rodríguez Güell, Elisabeth ^a   Agustí, Gemma ^a   Corominas, Mercè ^b   Luquin, Marina ^a   Julián, Esther ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL WALL SKELETON; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MYCOBACTERIUM VACCAE; PRIORITY JOURNAL;

ADULT; ANTIGENS, BACTERIAL; CELLS, CULTURED; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM; TUBERCULOSIS, PULMONARY;

EID: 51649085111     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00131-08     Document Type: Article

References (15)

1. Al-Attiyah, R., A. S. Mustafa, A. T. Abal, N. M. Madi, and P. Andersen. 2003. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol. Med. Microbiol. 38:249-256.
2. Dlugovitzky, D., M. L. Bay, L. Rateni, G. Fiorenza, L. Vietti, M. A. Farroni, and O. A. Bottasso. 2000. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin. Exp. Immunol. 122:343-349.
3. Dlugovitzky, D., O. Bottasso, J. C. Dominino, E. Valentini, R. Hartopp, M. Singh, C. Stanford, and J. Stanford. 1999. Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). Respir. Med. 93:557-562.
4. Dlugovitzky, D., G. Fiorenza, M. Farroni, C. Bogue, C. Stanford, and J. Stanford. 2006. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis. Respir. Med. 100:1079-1087.
5. Jamil, B., F. Shahid, Z. Hasan, N. Nasir, T. Razzaki, G. Dawood, and R. Hussain. 2007. Interferon gamma/IL-10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis 87:279-287.
6. Johnson, J. L., R. M. Kamya, A. Okwera, A. M. Loughlin, S. Nyole, D. L. Horn, R. S. Wallis, C. S. Hirsch, K. Wolski, J. Foulds, R. D. Mugerwa, and J. J. Ellner. 2000. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis. J. Infect. Dis. 181:1304-1312.
7. Johnson, J. L., A. J. Nunn, P. B. Fourie, L. P. Ormerod, R. D. Mugerwa, A. Mwinga, C. Chintu, B. Ngwira, P. Onyebujoh, and A. Zumla. 2004. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis. Int. J. Tuberc. Lung Dis. 8:1348-1354.
8. Mazzarella, G., A. Bianco, F. Perna, D. D'Auria, E. Grella, E. Moscariello, and A. Sanduzzi. 2003. T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitaiy tuberculosis. Clin. Exp. Immunol. 132:283-288.
9. Rodríguez-Güell, E., G. Agustí, M. Corominas, P.-J. Cardona, I. Casals, T. Parella, M. A. Sempere, M. Luquin, and E. Julián. 2006. The production of a new extracellular putative long-chain saturated polyester by smooth variants of Mycobacterium vaccae interferes with Th1-cytokine production. Antonie van Leeuwenhoek 90:93-108.
10. Rodríguez-Güell, E., G. Agustí, M. Corominas, P. J. Cardona, M. Luquin, and E. Julián. 2008. Mice with pulmonary tuberculosis treated with Mycobacterium vaccae develop strikingly enhanced recall gamma interferon responses to M. vaccae cell wall skeleton. Clin. Vaccine Immunol. 15:893-896.
11. Rook, G. A., K. Dheda, and A. Zumla. 2005. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5:661-667.
12. Sahiratmadja, E., B. Alisjahbana, T. de Boer, I. Adnan, A. Maya, H. Danusantoso, R. H. Nelwan, S. Marzuki, J. W. van der Meer, R. van Crevel, E. van de Vosse, and T. H. Ottenhoff. 2007. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829.
13. Sodhi, A., J. Gong, C. Silva, D. Qian, and P. F. Barnes. 1997. Clinical correlates of interferon gamma production in patients with tuberculosis. Clin. Infect. Dis. 25:617-620.
14. Stanford, J., C. Stanford, and J. Grange. 2004. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front. Biosci. 9:1701-1719.
15. Wu, H. P., C. C. Hua, and D. Y. Chuang. 2007. Decreased in vitro interferon-gamma production in patients with cavitary tuberculosis on chest radiography. Respir. Med. 101:48-52.